JP2018513864A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513864A5
JP2018513864A5 JP2017554855A JP2017554855A JP2018513864A5 JP 2018513864 A5 JP2018513864 A5 JP 2018513864A5 JP 2017554855 A JP2017554855 A JP 2017554855A JP 2017554855 A JP2017554855 A JP 2017554855A JP 2018513864 A5 JP2018513864 A5 JP 2018513864A5
Authority
JP
Japan
Prior art keywords
dosage form
active ingredient
pharmacologically active
form according
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017554855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018513864A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/058977 external-priority patent/WO2016170093A1/en
Publication of JP2018513864A publication Critical patent/JP2018513864A/ja
Publication of JP2018513864A5 publication Critical patent/JP2018513864A5/ja
Withdrawn legal-status Critical Current

Links

JP2017554855A 2015-04-24 2016-04-22 粒子及びマトリックスから２種の薬物の急速放出をもたらすタンパレジスタントな固定用量組合せ Withdrawn JP2018513864A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15165070 2015-04-24
EP15165070.2 2015-04-24
PCT/EP2016/058977 WO2016170093A1 (en) 2015-04-24 2016-04-22 Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix

Publications (2)

Publication Number Publication Date
JP2018513864A JP2018513864A (ja) 2018-05-31
JP2018513864A5 true JP2018513864A5 (enExample) 2019-05-30

Family

ID=53015581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017554855A Withdrawn JP2018513864A (ja) 2015-04-24 2016-04-22 粒子及びマトリックスから２種の薬物の急速放出をもたらすタンパレジスタントな固定用量組合せ

Country Status (8)

Country Link
US (1) US20160310486A1 (enExample)
EP (1) EP3285744A1 (enExample)
JP (1) JP2018513864A (enExample)
AU (1) AU2016251302A1 (enExample)
BR (1) BR112017022335A2 (enExample)
CA (1) CA2983648A1 (enExample)
MX (1) MX2017013643A (enExample)
WO (1) WO2016170093A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3473246A1 (en) 2017-10-19 2019-04-24 Capsugel Belgium NV Immediate release abuse deterrent formulations
EP3727384A4 (en) 2017-12-20 2021-11-03 Purdue Pharma L.P. ABUSE-DISSUASIVE MORPHINE SULPHATE FORMES
EP3679926A1 (en) * 2019-01-14 2020-07-15 APTYS Pharmaceuticals SAS A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141250B2 (en) 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US20030092724A1 (en) 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
HRP20070456T3 (en) 2003-08-06 2007-11-30 Grnenthal Gmbh Dosage form that is safeguarded from abuse
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
EP1740156B8 (de) 2004-04-22 2012-07-11 Grünenthal GmbH Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
PL1786403T3 (pl) 2004-07-01 2013-10-31 Gruenenthal Gmbh Doustna postać dawki zabezpieczona przed nadużywaniem zawierająca (1R, 2R)-3-(3-dimetyloamino-1-etylo0-2-metylo-propylo)fenol
EP1765298B1 (de) 2004-07-01 2012-10-24 Gruenenthal Gmbh Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreichungsform unter verwendung eines planetwalzenextruders
CA2572491A1 (en) 2004-07-01 2006-01-12 Gruenenthal Gmbh Oral dosage form safeguarded against abuse
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
KR20130135403A (ko) 2005-05-10 2013-12-10 노파르티스 아게 압축성이 열등한 치료학적 화합물을 갖는 조성물을 제조하는 압출방법
US8652529B2 (en) 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
US20070292508A1 (en) 2006-06-05 2007-12-20 Balchem Corporation Orally disintegrating dosage forms
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko) 2008-01-25 2016-05-02 그뤼넨탈 게엠베하 약제학적 투여형
PL2273983T3 (pl) 2008-05-09 2017-01-31 Grünenthal GmbH Sposób wytwarzania pośredniego preparatu proszkowego i końcowej stałej postaci dawkowania z zastosowaniem etapu zestalania rozpyłowego
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
PE20121067A1 (es) 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
PE20120631A1 (es) 2009-07-22 2012-06-06 Gruenenthal Chemie Forma de dosificacion resistente a la manipulacion para opioides sensibles a la oxidacion
ES2606227T3 (es) 2010-02-03 2017-03-23 Grünenthal GmbH Preparación de una composición farmacéutica en polvo mediante una extrusora
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
KR20130097201A (ko) 2010-09-02 2013-09-02 그뤼넨탈 게엠베하 음이온성 중합체를 포함하는 내변조성 투여형
US20120202838A1 (en) * 2010-11-04 2012-08-09 Abbott Laboratories Drug formulations
US8858963B1 (en) * 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
SI2736495T1 (sl) 2011-07-29 2017-12-29 Gruenenthal Gmbh Tableta, odporna proti zlorabi, ki zagotavlja takojšnje sproščanje zdravila
PE20141650A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
FR2979242A1 (fr) 2011-08-29 2013-03-01 Sanofi Sa Comprime contre l'usage abusif, a base de paracetamol et d'oxycodone
JP2014528437A (ja) 2011-10-06 2014-10-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング オピオイドアゴニストおよびオピオイドアンタゴニストを含むタンパーレジスタント経口医薬剤形
AR088875A1 (es) 2011-11-17 2014-07-16 Gruenenthal Gmbh Forma de dosis farmaceutica oral a prueba de manipulacion
US20130225625A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
EP2819656A1 (en) 2012-02-28 2015-01-07 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EP2819653B1 (en) * 2012-03-02 2017-01-11 Rhodes Pharmaceuticals L.P. Tamper resistant immediate release formulations
RS57913B1 (sr) 2012-04-18 2019-01-31 Gruenenthal Gmbh Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
CN104428002B (zh) 2012-05-11 2017-08-11 格吕伦塔尔有限公司 热成形的抗篡改含锌药物剂型
JP2016512248A (ja) * 2013-03-15 2016-04-25 マリンクロッド エルエルシー 食事に関係なく投与され得る、痛覚消失の急速な開始および期間の延長のためのオピオイドおよびさらなる活性医薬成分を含む組成物
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US9737490B2 (en) * 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
CA2817728A1 (en) 2013-05-31 2014-11-30 Pharmascience Inc. Abuse deterrent immediate release formulation
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer

Similar Documents

Publication Publication Date Title
JP2018513872A5 (enExample)
AU2017272152B2 (en) Pain Medicine Combination and Uses Thereof
AU2011271429B2 (en) Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
JP5835865B2 (ja) ロキソプロフェン含有医薬組成物
JP6040218B2 (ja) 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
JP2015044834A5 (enExample)
JP2002538221A (ja) 抗てんかん作用を有する化合物を包含する鎮痛組成物およびその使用方法
CN106456550A (zh) 避免乙醇剂量倾泻的多颗粒
JP2002538176A (ja) トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物
TW200427469A (en) Pharmaceutical compositions of varenicline
HU227514B1 (en) Controlled release oxycodone compositions
JP2007505154A5 (enExample)
JP2009540014A (ja) 胃障害を処置または予防するためのテガセロドを単独でまたはプロトンポンプ阻害剤と組合せて含む組成物
JP5897804B2 (ja) ロキソプロフェン含有の医薬組成物
PT1355631E (pt) Formulação oral de desintegração rápida de um inibidor da ciclooxigenase-2
RU2011104146A (ru) Фармацевтическая композиция, содержащая опиоидный антагонист, для лечения задержки мочи
JP2018513864A5 (enExample)
US9205081B2 (en) Combinations of opiod/TLR4 antagonist and a cyclooxygenase (COX) inhibitor for use in the treatment of pain
JP2018515455A5 (enExample)
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
JP2018515456A5 (enExample)
Herbert et al. The enantiomers of tramadol and its major metabolite inhibit peristalsis in the guinea pig small intestine via differential mechanisms
US8598221B2 (en) Synergistic combination of analgesic compounds
WO2009002299A1 (en) Method for treating warm-blooded vertebrates with halide-free glucosamine-acidic drug complexes
AU2010295464B2 (en) Use of opioid receptor antagonist for gastrointestinal tract disorders